All stock lists
IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
33.23-1.48 (-4.26%)
Insider Score
––Not scored
IDYA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
IDYA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 8.86 M | 6.56 M | 10.88 M | 207.83 M | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | 55.37 % | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 8.86 M | 6.56 M | 10.88 M | 207.83 M | 0.00 | 0.00 |
| SG&A Expense | 22.46 M | 19.38 M | 18.85 M | 16.39 M | 14.58 M | 13.50 M |
| R&D Expense | 108.69 M | 95.73 M | 86.60 M | 82.99 M | 74.23 M | 70.89 M |
| Operating Expenses | 131.15 M | 115.10 M | 105.45 M | 99.38 M | 88.81 M | 84.39 M |
| Operating Income | -122.29 M | -108.54 M | -94.57 M | 108.45 M | -88.81 M | -84.39 M |
| Pretax Income | -112.45 M | -98.54 M | -83.27 M | 119.24 M | -77.49 M | -72.18 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -112.45 M | -98.54 M | -83.27 M | 119.24 M | -77.49 M | -72.18 M |
| EPS (Basic) | -1.22 | -1.11 | -0.94 | 1.35 | -0.88 | -0.82 |
| EPS (Diluted) | -1.22 | -1.11 | -0.94 | 1.33 | -0.88 | -0.82 |
| Shares Outstanding | 92.06 M | 88.70 M | 88.58 M | 88.53 M | 88.47 M | 88.36 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.